Status:
COMPLETED
Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management
Lead Sponsor:
Azienda Ospedaliero-Universitaria di Modena
Conditions:
Cutaneous Melanoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The incidence of cutaneous melanoma (MM) is increasing worldwide. The best therapeutical solution for MM is early diagnosis and efforts over the last 50 years have been directed towards early and prec...
Eligibility Criteria
Inclusion
- \- Patient's with at least 1 unequivocal lesion following standard of care (clinical and dermoscopy evaluations), \>= 18 years old
Exclusion
- (i) the presence of an unequivocal aspect of melanoma or of any other malignant skin cancer,
- (ii) lesion located on a skin area where reflectance confocal microscopy cannot be performed (for example: skin folds, mucosa, etc.),
- (iii) lesion larger than 2 cm in its largest diameter
- (iv) lesion where RCM examination is hampered for over the 30% of its surface (for example, for presence of crusting, oozing, erosion, ulceration, etc.).
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2020
Estimated Enrollment :
3248 Patients enrolled
Trial Details
Trial ID
NCT04789421
Start Date
March 1 2016
End Date
March 16 2020
Last Update
March 9 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.